179 related articles for article (PubMed ID: 22894967)
1. Pneumococcal conjugate vaccine: a newer vaccine available in India.
Verma R; Khanna P
Hum Vaccin Immunother; 2012 Sep; 8(9):1317-20. PubMed ID: 22894967
[TBL] [Abstract][Full Text] [Related]
2. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.
Wahl B; O'Brien KL; Greenbaum A; Majumder A; Liu L; Chu Y; Lukšić I; Nair H; McAllister DA; Campbell H; Rudan I; Black R; Knoll MD
Lancet Glob Health; 2018 Jul; 6(7):e744-e757. PubMed ID: 29903376
[TBL] [Abstract][Full Text] [Related]
3. National, regional, and state-level burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in India: modelled estimates for 2000-15.
Wahl B; Sharan A; Deloria Knoll M; Kumar R; Liu L; Chu Y; McAllister DA; Nair H; Campbell H; Rudan I; Ram U; Sauer M; Shet A; Black R; Santosham M; O'Brien KL; Arora NK
Lancet Glob Health; 2019 Jun; 7(6):e735-e747. PubMed ID: 31097277
[TBL] [Abstract][Full Text] [Related]
4. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.
van Werkhoven CH; Huijts SM
Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal Vaccines - How Many Serotypes are Enough?
Singh A; Dutta AK
Indian J Pediatr; 2018 Jan; 85(1):47-52. PubMed ID: 28887787
[TBL] [Abstract][Full Text] [Related]
6. The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine.
McIntosh ED; Conway P; Willingham J; Lloyd A
Vaccine; 2003 Jun; 21(19-20):2564-72. PubMed ID: 12744892
[TBL] [Abstract][Full Text] [Related]
7. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
[TBL] [Abstract][Full Text] [Related]
8. The Pneumococcus and Its Critical Role in Public Health.
Oligbu G; Fry NK; Ladhani SN
Methods Mol Biol; 2019; 1968():205-213. PubMed ID: 30929217
[TBL] [Abstract][Full Text] [Related]
9. Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014.
Murray J; Agócs M; Serhan F; Singh S; Deloria-Knoll M; O'Brien K; Mwenda JM; Mihigo R; Oliveira L; Teleb N; Ahmed H; Wasley A; Videbaek D; Wijesinghe P; Thapa AB; Fox K; Paladin FJ; Hajjeh R; Schwartz S; Van Beneden C; Hyde T; Broome C; Cherian T;
MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1159-62. PubMed ID: 25503919
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.
Sutcliffe CG; Shet A; Varghese R; Veeraraghavan B; Manoharan A; Wahl B; Chandy S; Sternal J; Khan R; Singh RK; Santosham M; Arora NK
BMC Infect Dis; 2019 Jul; 19(1):605. PubMed ID: 31291902
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
13. The Epidemiology and Biostatistics of Pneumococcus.
Oligbu G; Fry NK; Ladhani SN
Methods Mol Biol; 2019; 1968():215-224. PubMed ID: 30929218
[TBL] [Abstract][Full Text] [Related]
14. Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India.
Ghia C; Wasserman M; Fletcher M; Farkouh R; Rambhad G
Value Health Reg Issues; 2018 May; 15():99-105. PubMed ID: 29655052
[TBL] [Abstract][Full Text] [Related]
15. The future of pneumococcal disease prevention.
Rodgers GL; Klugman KP
Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
[TBL] [Abstract][Full Text] [Related]
16. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in pneumococcal vaccination of children.
Russell FM; Mulholland EK
Ann Trop Paediatr; 2004 Dec; 24(4):283-94. PubMed ID: 15720885
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea.
Zhang XH; Leeuwenkamp O; Oh KB; Lee YE; Kim CM
Hum Vaccin Immunother; 2018 Jan; 14(1):85-94. PubMed ID: 29115905
[TBL] [Abstract][Full Text] [Related]
19. Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a "3+0" schedule.
Becker-Dreps S; Blette B; Briceño R; Alemán J; Hudgens MG; Moreno G; Ordoñez A; Rocha J; Weber DJ; Amaya E
PLoS One; 2017; 12(8):e0183348. PubMed ID: 28813518
[TBL] [Abstract][Full Text] [Related]
20. Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: Modeled effects in 8 country scenarios.
Carter ED; Tam Y; Walker N
Vaccine; 2019 Aug; 37(36):5242-5249. PubMed ID: 31375441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
